MedTrace Logo

Probiotics in Radiation-treated Gynecologic Cancer

NCT02351089 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 97

Last updated 2020-03-05

No results posted yet for this study

Summary

The aim of the current Project is to study the efficacy of a probiotic Product in reducing the symptoms of gastrointestinal toxicity linked to the irradiation of gynecologic cancer.

Conditions

  • Gastrointestinal Toxicity
  • Gynecologic Cancer

Interventions

DIETARY_SUPPLEMENT

Capsules placebo

Capsules

DIETARY_SUPPLEMENT

Capsules probiotic powder and corn starch

Sponsors & Collaborators

  • Probi AB

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2018-12-31
Completion
2019-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02351089 on ClinicalTrials.gov